Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-202381
Filing Date
2026-05-04
Accepted
2026-05-04 06:01:30
Documents
1
Period of Report
2026-04-29

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4014
  Complete submission text file 0001193125-26-202381.txt   5499
Mailing Address 105 W FIRST ST. BOSTON MA 02127
Business Address 105 W FIRST ST. BOSTON MA 02127 (206) 707-0340
Avalyn Pharma Inc. (Issuer) CIK: 0001540171 (see all company filings)

EIN.: 452463191 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVALYN PHARMA INC. 105 W FIRST STREET BOSTON MA 02127
Business Address
Golden Adam H. (Reporting) CIK: 0002130116 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-43251 | Film No.: 26934475